Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
20/20 Biolabs, Inc. - Common Stock
(NQ:
AIDX
)
1.880
+0.040 (+2.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
150,366
Open
1.830
Bid (Size)
1.700 (300)
Ask (Size)
1.920 (400)
Prev. Close
1.840
Today's Range
1.680 - 1.980
52wk Range
1.510 - 50.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
April 10, 2026
Via
ACCESS Newswire
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
April 07, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Performance
YTD
-92.1%
-92.1%
1 Month
-30.6%
-30.6%
3 Month
-92.1%
-92.1%
6 Month
-92.1%
-92.1%
1 Year
-92.1%
-92.1%
More News
Read More
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
March 31, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test
March 27, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
What's Going On With 20/20 Biolabs Stock?
↗
March 24, 2026
Via
Benzinga
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
March 24, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
March 12, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities
February 25, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
February 20, 2026
From
20/20 Biolabs Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is 20/20 Biolabs, Inc. - Common Stock publicly traded?
Yes, 20/20 Biolabs, Inc. - Common Stock is publicly traded.
What exchange does 20/20 Biolabs, Inc. - Common Stock trade on?
20/20 Biolabs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 20/20 Biolabs, Inc. - Common Stock?
The ticker symbol for 20/20 Biolabs, Inc. - Common Stock is AIDX on the Nasdaq Stock Market
What is the current price of 20/20 Biolabs, Inc. - Common Stock?
The current price of 20/20 Biolabs, Inc. - Common Stock is 1.880
When was 20/20 Biolabs, Inc. - Common Stock last traded?
The last trade of 20/20 Biolabs, Inc. - Common Stock was at 04/10/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.